StockData
IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV) stock

IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3013% above fair value
$245.82−4.73 (-1.89%)

Close on Nov 20, 2026Market cap $40.51BP/E 29.9Yield –

Iqvia free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Iqvia's free cash flow for the twelve months ending Sep 30, 2026 was $2.08B, down 6.0% year over year. For fiscal 2025 it was $2.05B, down 3.0% from the year before. Over ten years it grew 17.8% a year on average. The highest annual figure on record is $2.30B in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.05B-3.0%
FY2024Dec 31, 2024$2.11B+40.9%
FY2023Dec 31, 2023$1.50B-5.4%
FY2022Dec 31, 2022$1.59B-31.1%
FY2021Dec 31, 2021$2.30B+71.4%
FY2020Dec 31, 2020$1.34B+60.8%
FY2019Dec 31, 2019$835.00M+5.0%
FY2018Dec 31, 2018$795.00M+32.3%
FY2017Dec 31, 2017$601.00M-13.6%
FY2016Dec 31, 2016$696.00M+74.9%
FY2015Dec 31, 2015$398.00M+13.7%
FY2014Dec 31, 2014$350.00M+14.7%
FY2013Dec 31, 2013$305.02M+15.4%
FY2012Dec 31, 2012$264.37M+210.0%
FY2011Dec 31, 2011$85.27M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$667.00M-13.6%
Q2 FY2026Jun 30, 2026$360.00M+23.3%
Q1 FY2026Mar 31, 2026$491.00M+15.3%
Q4 FY2025Dec 31, 2025$561.00M-22.2%
Q3 FY2025Sep 30, 2025$772.00M+35.2%
Q2 FY2025Jun 30, 2025$292.00M-34.4%
Q1 FY2025Mar 31, 2025$426.00M+13.0%
Q4 FY2024Dec 31, 2024$721.00M+26.9%
Q3 FY2024Sep 30, 2024$571.00M+30.7%
Q2 FY2024Jun 30, 2024$445.00M+83.9%
Q1 FY2024Mar 31, 2024$377.00M+49.0%
Q4 FY2023Dec 31, 2023$568.00M+46.0%
Q3 FY2023Sep 30, 2023$437.00M-37.4%
Q2 FY2023Jun 30, 2023$242.00M+44.0%
Q1 FY2023Mar 31, 2023$253.00M-23.6%
Q4 FY2022Dec 31, 2022$389.00M-23.4%
Q3 FY2022Sep 30, 2022$698.00M+2.3%
Q2 FY2022Jun 30, 2022$168.00M-57.4%
Q1 FY2022Mar 31, 2022$331.00M-53.9%
Q4 FY2021Dec 31, 2021$508.00M-11.5%
Q3 FY2021Sep 30, 2021$682.00M+63.5%
Q2 FY2021Jun 30, 2021$394.00M+19.4%
Q1 FY2021Mar 31, 2021$718.00M+3163.6%
Q4 FY2020Dec 31, 2020$574.00M+28.7%
Q3 FY2020Sep 30, 2020$417.00M+130.4%
Q2 FY2020Jun 30, 2020$330.00M+39.8%
Q1 FY2020Mar 31, 2020$22.00M–
Q4 FY2019Dec 31, 2019$446.00M+59.9%
Q3 FY2019Sep 30, 2019$181.00M-18.1%
Q2 FY2019Jun 30, 2019$236.00M+17.4%
Q1 FY2019Mar 31, 2019-$28.00M-129.8%
Q4 FY2018Dec 31, 2018$279.00M+113.0%
Q3 FY2018Sep 30, 2018$221.00M-36.3%
Q2 FY2018Jun 30, 2018$201.00M+38.6%
Q1 FY2018Mar 31, 2018$94.00M–
Q4 FY2017Dec 31, 2017$131.00M-63.7%
Q3 FY2017Sep 30, 2017$347.00M–
Q2 FY2017Jun 30, 2017$145.00M–
Q1 FY2017Mar 31, 2017-$22.00M–
Q4 FY2016Dec 31, 2016$361.00M–

More Iqvia figures

See a number that looks wrong?